Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Abbott announces quarterly common dividend increase

Amgen announces Q1 2026 dividend

Eli Lilly announces Q1 2026 dividend

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Amgen announces Q4 2025 dividend

Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses

Perrigo to pay quarterly dividend of USD0.290 per share

Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities

Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio

IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera

AstraZeneca strikes landmark drug pricing deal with US Government

Aptamer Group wins GBP360,000 contract with global pharmaceutical company for radiopharmaceutical development

Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client